Serum vitamin B12 tests may not always catch functional deficiencies. Therefore, methylmalonic acid (MMA) is a preferred, more reliable marker for assessing vitamin B12 status, which is crucial for diagnosing various metabolic disorders.
“MMA is a more dependable marker because it reflects intracellular B12 activity,” advises Bryan Tackett, Ph.D., Product Marketing Manager at Phenomenex. “When MMA is elevated, it signals impaired B12 utilization—even when serum B12 appears normal—allowing more confident clinical decisions.”
Analytical Challenges in Measuring MMA
However, analyzing MMA presents some distinct technical hurdles. It exists at low ng/mL concentrations and is isobaric with a structurally similar compound.
“MMA is difficult to quantify because it is isobaric with succinic acid and both compounds are highly polar,” Tackett notes. “They share similar pKa values and low logP, which limits retention on standard reversed-phase columns. On top of that, succinic acid can be 10 to 100 times more abundant,” he warns. “So if you don’t resolve them, you risk skewed results.”
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
“Without sufficient separation, succinic acid can interfere and produce false elevations in MMA measurements,” adds Tackett.
A Refined LC–MS/MS Workflow for Accuracy
To address these challenges, Tackett describes a quantitative LC–MS/MS workflow optimized for clinical research. Sample preparation relies on supported liquid extraction (SLE) to improve matrix cleanup and reproducibility.
“An SLE workflow provides meaningful gains in data quality over protein precipitation,” he explains. “It reduces ion suppression, improves reproducibility, and delivers cleaner baselines—especially at low concentrations.”
“You’re essentially removing more of the biological noise before it ever reaches the mass spectrometer.”
Tackett advises that pre-extraction acidification plays a key role in performance.“Acidification helps dissociate MMA from protein binding and improves transfer into the extraction phase. At low pH, MMA becomes uncharged, which enhances partitioning into the organic solvent while maintaining stability.”
“That balance—strong enough to release the analyte, but gentle enough to preserve it—is critical,” he adds.
Chromatographic separation uses a polar-embedded, positively charged C18 stationary phase under HILIC-like conditions.
“This setup combines electrostatic attraction and hydrophobic interaction,” Tackett explains. “MMA interacts more strongly with the stationary phase, leading to longer retention and clear separation from succinic acid. You’re effectively using two retention mechanisms at once to create selectivity.”
Proven Separation and Validation Metrics
The method achieves baseline separation of MMA and succinic acid, with distinct retention times.
“We confirmed resolution through stable retention times, distinct peak shapes, and MRM transitions with no co-elution—even in blank serum samples,” Tackett says. “That level of separation is what prevents false highs and keeps your baseline clean day to day.”
Matrix effects were evaluated using recovery, coefficient of variation, and process-efficiency metrics.
“The most effective way to control matrix effects was the SLE cleanup combined with an optimized extraction solvent,” he explains. “This approach delivered high recovery, low variability, and minimal interference. Once you control matrix effects, your quantification becomes far more reliable across runs.”
In mass spectrometry, negative electrospray ionization (ESI) improves sensitivity for acidic analytes.
“Negative ESI is inherently well-suited for small acidic molecules like MMA,” Tackett observes. “Optimizing ion spray voltage, temperature, and gas flow significantly improves signal intensity. Those source conditions make a measurable difference in sensitivity at the low end.”
The calibration range spans 1–1000 ng/mL with strong linearity, supporting accurate quantification across the clinical spectrum.
“This range captures everything from healthy levels to clear deficiency,” asserts Tackett. “It enables early detection, diagnosis, and monitoring of B12-related metabolic imbalances. You can run diverse patient samples without rework or dilution steps.”
Clinical Relevance and Research Impact
This level of performance supports a wide range of applications, from clinical research to population studies.
“A broad and linear calibration range allows labs to analyze all patient states in a single run,” describes Tackett. “That improves efficiency while maintaining accuracy across the entire clinical spectrum. It also supports screening and longitudinal monitoring without changing methods.”
Expert Recommendations
Tackett highlights three priorities for successful implementation:
Use supported liquid extraction to minimize matrix effects.
Apply HILIC-like conditions using polar-embedded stationary phases to enhance selectivity.
Optimize MS parameters in negative ESI for sensitivity.
“Focus on sample cleanup and separation first—those drive most of your accuracy,” he advises.
He also emphasizes one critical risk. “The most common pitfall is insufficient chromatographic resolution from succinic acid. If separation is not validated, false positives can occur. Always verify resolution with retention time stability and MRM confirmation before routine use.”
By combining effective sample cleanup, selective chromatography, and optimized detection, this LC–MS/MS workflow delivers a robust solution for the quantitative determination of methylmalonic acid. The result is a reliable approach for assessing functional vitamin B12 deficiency with confidence in clinical research settings.
